Long-term survival in extensive-stage small-cell lung cancer treated with different immune checkpoint inhibitors in multiple-line therapies: A case report and literature review

BACKGROUND: Extensive-stage small-cell lung cancer (ES-SCLC) is highly malignant, is highly prone to recurrence, and has a short survival period. It is very difficult to achieve long-term survival in ES-SCLC, which has not been significantly improved in the last 20 years. For a long time, platinum-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xu, Zheng, Jiabin, Niu, Yun, Xue, Chongxiang, Yu, Yixuan, Tan, Kexin, Cui, Huijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747940/
https://www.ncbi.nlm.nih.gov/pubmed/36532013
http://dx.doi.org/10.3389/fimmu.2022.1059331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747940/
https://www.ncbi.nlm.nih.gov/pubmed/36532013
http://dx.doi.org/10.3389/fimmu.2022.1059331

Ejemplares similares